2FIGURA N, ARMELLINI D, BUGNOLI M,et al. Activity of omeprazole on Helicobacter pylori and relation to toxicity of strains[J]. J Clin Pathol, 1994,47(2):440-442.
3PAPINI E, BUGNOLI M, DE BERNARD M, et al. Bafiliomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells[J]. Mol Microbiol, 1993,7(2):323-327.
4MAUCH F, BODE G. Identification and characterization of an ATPase system of helicobacter pylori and the effect of proton pump inhibitors[J]. Am J Gastroenterol, 1993,88(10):1801-1802.
5PAGLIACCIA C, DE BERNARED M, LUPETTI P, et al. The m 2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity[J]. Proc Natl Acad Sci USA, 1998,95(17):10212-12017.
6Jones KR, Whitmire JM, Meirell DS. A tale of two toxins: Heli-cobacter pylori CagA and VacA modulate host pathways that im-pact disease[ J] . Front Microbiol, 2010,23( 1 ) ; 1151 -1517.
7Rassow J, Meinecke M. Helicobacter pylori VacA: a new per-spective on an invasive chloride channel [ J]. Microbes Infect,2012,14(12); 1026-1033.
8de Bernard M, Papini E, Filippis V,ei al. Low pH activates thevacuolating toxin of Helicobacter pylori,which becomes acid andpepsin resistant[J]. Biol J Biol Chem, 1995,270(41) : 23937 -23940.
9Molinari M,Galli C,Norais N,et al. Vacuoles induced by Heli-cobacter pylori toxin contain both late endosomal and lysosomalmarkers[J]. J Biol Chem, 1997,272(40) : 25339 -25344.
10Romano M,Ricci V,Zanilli R. Mechanisms of disease: Helico-bacter pylori related gastric carcinogenesis-implications for chemo-prevention[ J]. Nat Clin Pract Gastroenterol Hepatol,2006,3(11): 622 -632.
